Earnings History Data for Novan, Inc. (NOVN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Novan, Inc.

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through Nitricil technology(TM). Novan, Inc. is based in Durham, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2023	PM	7:00 AM ET (May 15)	NOVN	Novan, Inc.	35.86	-0.54	-0.32	-0.71	Novan GAAP EPS of -$0.54 misses by $0.22, revenue of $3.17M misses by $3.02M [5/15/2023 6:49 AM]	1.16	-0.12 (-9.77%)	0.0	0.0 (0.00%)	0.79 - 3.33	217,073	100,000	0
Novan GAAP EPS of -$0.54 misses by $0.22, revenue of $3.17M misses by $3.02M [5/15/2023 6:49 AM]
30-03-2023	PM	7:00 AM ET (Mar 30)	NOVN	Novan, Inc.	34.74	-0.09	-0.31	-0.44	Novan GAAP EPS of -$1.42 beats by $0.10, revenue of $23.7M beats by $4.34M [3/30/2023 6:33 AM]	1.20	0.09 (8.11%)	1.17	0.06 (5.41%)	0.79 - 4.09	162,066	100,000	3,931
Novan GAAP EPS of -$1.42 beats by $0.10, revenue of $23.7M beats by $4.34M [3/30/2023 6:33 AM] Novan rises 12% on full-year result beat [3/30/2023 1:30 PM]
14-11-2022	PM	6:30 AM ET (Nov 14)	NOVN	Novan, Inc.	21.49	-0.43	-0.39	-0.34	Novan GAAP EPS of -$0.25 beats by $0.14, revenue of $5.11M misses by $1.17M [11/14/2022 7:07 AM]	0.8797	-0.14 (-13.75%)	1.05	0.03 (2.94%)	0.79 - 6.75	905,235	270,000	32,175
Novan GAAP EPS of -$0.25 beats by $0.14, revenue of $5.11M misses by $1.17M [11/14/2022 7:07 AM] Novan stock tumbles 18% on Q3 revenue miss as key skin drugs sales fall Q/Q [11/14/2022 11:56 AM] Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-14-22 07:00AM]
11-08-2022	PM	6:30 AM ET (Aug 11)	NOVN	Novan, Inc.	60.87	-0.44	-0.59	-0.39	Novan GAAP EPS of -$0.44 beats by $0.15, revenue of $6.16M misses by $0.44M [8/11/2022 6:37 AM]	2.92	0.03 (0.86%)	2.98	0.08 (2.76%)	2.15 - 10.58	155,112	90,000	2,403
Novan Q2 2022 Earnings Preview [8/10/2022 1:53 PM] Novan GAAP EPS of -$0.44 beats by $0.15, revenue of $6.16M misses by $0.44M [8/11/2022 6:37 AM] Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-11-22 06:30AM]
16-05-2022	PM	7:00 AM ET (May 16)	NOVN	Novan, Inc.	45.19	-0.71	-0.57	-0.60	Novan GAAP EPS of -$0.71, revenue of $1.9M [5/16/2022 6:32 AM]	2.50	0.11 (4.60%)	2.38	-0.01 (-0.42%)	2.24 - 20.74	73,172	90,000	4,249
Novan GAAP EPS of -$0.71, revenue of $1.9M [5/16/2022 6:32 AM] Novan Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-16-22 06:30AM]
22-02-2022	PM	5:55 AM ET (Feb 22)	NOVN	Novan, Inc.	77.71	-0.44	-0.41	-0.70	Novan GAAP EPS of -$1.74, revenue of $2.96M [2/22/2022 7:07 AM]	3.64	-0.29 (-7.38%)	3.69	-0.24 (-6.11%)	2.71 - 20.80	213,156	130,000	578
Novan GAAP EPS of -$1.74, revenue of $2.96M [2/22/2022 7:07 AM] Novan Reports Full Year 2021 Financial Results and Provides Corporate Update [Feb-22-22 07:00AM]
10-11-2021	PM	7:05 AM ET (Nov 10)	NOVN	Novan, Inc.	131.88	-0.34	-0.41	-0.60	Novan EPS beats by $0.08, misses on revenue [11/10/2021 6:32 AM]	6.59	-0.50 (-7.05%)	7.12	0.03 (0.42%)	4.61 - 25.90	495,646	310,000	3,913
Novan Q3 2021 Earnings Preview [11/9/2021 11:47 AM] Novan EPS beats by $0.08, misses on revenue [11/10/2021 6:32 AM] Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19 [Nov-09-21 08:35AM] Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-10-21 05:55AM]
12-08-2021	PM	7:30 AM ET (Aug 12)	NOVN	Novan, Inc.	157.60	-0.39	-0.53	-0.70	Novan EPS beats by $0.14, misses on revenue [8/12/2021 7:13 AM]	9.65	1.29 (15.43%)	8.34	-0.02 (-0.24%)	3.00 - 25.90	6,943,123	550,000	6,237
Novan EPS beats by $0.14, misses on revenue [8/12/2021 7:13 AM] Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-12-21 07:05AM]
11-05-2021	AH	After the close (May 11)	NOVN	Novan Inc.	185.00	-0.06	-0.05	0.00	Novan EPS misses by $0.01, misses on revenue [5/11/2021 4:29 PM]	1.10	-0.05 (-4.76%)	1.14	-0.02 (-1.30%)	0.30 - 2.59	1,838,866	3,250,000	52,874
Novan EPS misses by $0.01, misses on revenue [5/11/2021 4:29 PM] Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-11-21 04:05PM]
30-10-2020	PM		NOVN	Novan Inc.	66.00	-0.06	-0.06	0.00	Novan EPS in-line, beats on revenue [10/30/2020 7:46 AM]	0.4601	-0.01 (-3.08%)	0.47	0.0 (-0.99%)	0.22 - 3.72	2,081,699	4,823,514	155,349